These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7697466)

  • 21. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA.
    Dimitrova P; Yordanov M; Danova S; Ivanovska N
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):231-6. PubMed ID: 18507679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice.
    Lucas R; Villamón E; Payá M; Alves M; del Olmo E; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):239-42. PubMed ID: 15039100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione.
    Gyetvai A; Emri T; Fekete A; Varga Z; Gazdag Z; Pesti M; Belágyi J; Emõdy L; Pócsi I; Lenkey B
    FEMS Yeast Res; 2007 Mar; 7(2):265-75. PubMed ID: 17266730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans.
    Basu S; Quilici C; Zhang HH; Grail D; Dunn AR
    Growth Factors; 2008 Feb; 26(1):23-34. PubMed ID: 18365876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
    Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
    Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
    Vonk AG; Netea MG; van Krieken JH; Iwakura Y; van der Meer JW; Kullberg BJ
    J Infect Dis; 2006 May; 193(10):1419-26. PubMed ID: 16619190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inflammation and resistance of mice infected by "Candida albicans" (author's transl)].
    Hurtrel B; Lagrange PH; Michel JC
    Ann Immunol (Paris); 1978; 129 C(6):843-6. PubMed ID: 371518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between Candida albicans epidermolytic proteinase activity and virulence in mice.
    Louie A; Dixon DM; el-Maghrabi EA; Burnett JW; Baltch AL; Smith RP
    J Med Vet Mycol; 1994; 32(1):59-64. PubMed ID: 8207623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host resistance to Candida albicans infection of mice with collagen-induced arthritis treated with leflunomide.
    Dimitrova P; Ivanovska N
    Res Microbiol; 2006; 157(6):525-30. PubMed ID: 16797932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines.
    Villamón E; Gozalbo D; Roig P; Murciano C; O'Connor JE; Fradelizi D; Gil ML
    Eur Cytokine Netw; 2004; 15(3):263-71. PubMed ID: 15542452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fas-FasL interactions modulate host defense against systemic Candida albicans infection.
    Netea MG; van Der Meer JW; Meis JF; Kullberg BJ
    J Infect Dis; 1999 Nov; 180(5):1648-55. PubMed ID: 10515828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans.
    Han Y
    Phytomedicine; 2007 Nov; 14(11):733-8. PubMed ID: 17913484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses.
    Utsunomiya T; Kobayashi M; Ito M; Pollard RB; Suzuki F
    Clin Immunol; 2000 May; 95(2):145-55. PubMed ID: 10779408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunostimulating properties of an extract isolated from Aloe vahombe. 2. Protection in mice by fraction F1 against infections by Listeria monocytogenes, Yersinia pestis, Candida albicans and Plasmodium berghei].
    Brossat JY; Ledeaut JY; Ralamboranto L; Rakotovao LH; Solar S; Gueguen A; Coulanges P
    Arch Inst Pasteur Madagascar; 1981; 48(1):11-34. PubMed ID: 7044327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-infection action of synthetic glycopeptides in an experiment on mice].
    Nikitina LE; Fridman EA; Noskov FS
    Tr Inst Im Pastera; 1982; 58():62-4. PubMed ID: 7187555
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of various antibiotics on granulopoiesis, in mice treated with cyclophosphamide, in an in vivo model of experimental C. albicans infection].
    Escande MC; Poyart-Salmeron C; Lagrange PH
    Pathol Biol (Paris); 1987 Dec; 35(10 Pt 2):1431-4. PubMed ID: 3325911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prophylactic efficacy of a basidiomycetes preparation AHCC against lethal Candida albicans infection in experimental granulocytopenic mice].
    Ikeda T; Ishibashi H; Fujisaki R; Yamazaki M; Wakame K; Kosuna K; Yamaguchi H; Ono Y; Abe S
    Nihon Ishinkin Gakkai Zasshi; 2003; 44(2):127-31. PubMed ID: 12748595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice.
    Bistoni F; Baccarini M; Blasi E; Marconi P; Puccetti P; Garaci E
    Infect Immun; 1983 Apr; 40(1):46-55. PubMed ID: 6339410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with oxoglaucine can enhance host resistance to Candida albicans infection of mice with adjuvant arthritis.
    Ivanovska N; Hristova M
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):17-20. PubMed ID: 11025179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.